Transcript Highlights:

• from such non-intoxicating cannabinoids shall be tested for contaminants and cannabinoid profile in
• from such non-intoxicating cannabinoids shall be tested for contaminants and cannabinoid profile in
• from such non-intoxicating cannabinoids shall be tested for contaminants and cannabinoid profile in
• So the synthetic cannabinoid is an ingredient, right?
• Well, they can't buy synthetic cannabinoids because we don't let them yet.

Keywords: 1191, senate, all

Transcript Highlights:

• "If you're asking what ibogaine is, ibogaine is a psychoactive alkaloid found in the root bark of the
• 00:54:14.800> a asking what is Ivagane, Iagane is a asking what is Ivagane, Iagane is a psychoactive
• 16.480> found<00:54:16.640> in<00:54:16.880> the<00:54:16.960> root psychoactive
• alkaloid found in the root psychoactive alkaloid found in the root bark<00:54:17.440> of<00:54

Keywords: Public Health and Welfare - Room 216, 25 February, 2026; 3:00 PM, 925, all

Summary: The committee first handled House Bill 612, which had been laid on the table because of questions about section one. Senator Tate explained that section one would allow the state, counties, and municipalities to enter interlocal agreements to provide installation support services on military installations, mainly road and infrastructure work such as paving and dirt work, and that section two would add Coast Guard medics to an existing provision allowing trained military medics to sit for LPN certification. After questions about the breadth of “installation support services,” the committee adopted the motion for title sufficient, due pass, with opposition noted, and the bill was reported to the Veterans and Military Affairs Committee. House Bill 942 was then passed over at Senator McMahon’s request until Tuesday. The committee then took up House Bill 1034, which would allow terminally ill hospital patients to use medical cannabis gummies. The sponsor said the bill is intended to help terminally ill patients who already qualify for medical cannabis but are denied access in hospitals, and that it prohibits smoking or inhalation. Members raised concerns about whether the bill was too broad, whether it would interfere with hospital and physician judgment, possible drug interactions, federal law issues, liability for hospitals and doctors, storage and disposal requirements, and whether hospitals would incur costs or be forced to handle cannabis on their premises. The sponsor responded that the patient’s use would be logged in the chart, that the caregiver is generally responsible for the lockbox and disposal, and that the bill includes language allowing a facility to opt out if compliance would jeopardize federal funding or licensing. The bill’s author also described the measure as arising from a Coast Guard family’s experience in which a terminally ill patient was denied access to medical cannabis at one hospital but allowed at another, and said the goal is to prevent similar denials for terminally ill patients. He said he was not aware of other drugs treated this way in hospitals, but argued that terminally ill patients should have access to most anything they want. The discussion ended with Senator England asking whether changing the bill’s requirement that a facility “shall” allow medical cannabis to “may” allow it would better protect hospitals and preserve discretion, but no final action on House Bill 1034 was taken in the portion provided.

Transcript Highlights:

• A lot of times meth or synthetic cannabinoids, K2, is actually soaked on pages.
• Choate said, you know, this day and age, you talk about things like synthetic cannabinoid, and to some
• But make no mistake, as committee members know, these synthetic cannabinoids that are coming into the
• system, there's no FDA-approved formula for making these synthetic cannabinoids, and oftentimes what
• Unfortunately, though, a lot of times it is just the synthetic cannabinoids. Okay.

Keywords: 1185, senate, all

Transcript Highlights:

• with the Rand Corporation to conduct this work, and Rand estimated the quantity of THC, the main psychoactive
• with the Rand Corporation to conduct this work, and Rand estimated the quantity of THC, the main psychoactive

Summary: The meeting began with JLARC’s biennial executive committee elections. After confirming a quorum, members unanimously elected Representative Pollet as chair, Senator Wagoner as vice chair, Representative Orcutt as secretary, and Senator Solomon as assistant secretary for the 2025-27 biennium. The committee also approved the May 14 meeting minutes unanimously. Chair Pollet then outlined a commitment to more member input on audit scope and coordination with the State Auditor’s Office. Staff presented a preliminary report on Washington State recreation boating programs. They reported that six agencies administer boating-related activities, that the state collected about $108 million in boating-related revenue in 2021-23, and that $86 million was spent, mostly on infrastructure and water access, environmental protection, boater safety, and marine law enforcement. Staff said Washington’s boating laws and programs are broadly similar to other states and noted that the final report is expected in September. JLARC then reviewed several tax preferences. For natural gas used as a transportation fuel, staff said the preferences reduce fuel costs but did not meet emissions-reduction targets because fewer vessels and vehicles converted to natural gas than expected; staff recommended continuing some exemptions and modifying reporting requirements. For travel agents and tour operators, staff said the preference continues to provide tax relief, but large beneficiaries’ savings are rising while small beneficiaries’ use is declining, leading to recommendations to continue the small-business rate and add or revise performance metrics. Staff also reviewed a nonprofit low-income housing property tax exemption, concluding it helps developers build homes as intended but that the performance metric should better reflect housing outcomes; they recommended the legislature decide whether to continue or modify it. Other reviews covered multipurpose senior citizen centers, disabled veteran adapted housing, trade convention attendance, agricultural fertilizer and seed wholesaling, hazardous substance tax treatment for pesticides, and silicon smelter energy preferences, with recommendations ranging from continuation to expiration depending on whether the stated objectives were met. The committee then adopted the final cannabis market study for distribution. Staff reported that Washington businesses produced two to three times more cannabis than retailers sold in 2023, and that inaccurate and incomplete reporting limits the Liquor and Cannabis Board’s ability to regulate the market. The board said it concurs with the recommendations, including developing a plan for a new data system and considering broader social equity options. Finally, staff presented the proposed final report on Department of Health oversight of hospital data reporting, inspections, and complaints. Staff said DOH was late on most acute-care hospital inspections, had not fully verified third-party inspection standards, and did not adequately review adverse event correction plans or assess language access barriers in its complaint system. DOH said it concurs with all six recommendations and has already made some transparency improvements, including a public dashboard for adverse event reporting.

Transcript Highlights:

• clarification on the requirements of ID scanning at cannabis sales facilities, the definition of synthetic cannabinoid
• clarification on the requirements of ID scanning at cannabis sales facilities, the definition of synthetic cannabinoid
• Section 10.3, synthetic cannabinoids.
• inclusion of additional defining language, expands what is not included in the definition of synthetic cannabinoids

Keywords: 909, all

Transcript Highlights:

• Currently, Hawaii has two cannabinoid product regulatory systems, one for medical cannabis and one for
• Delta-9 THC is the intoxicating cannabinoid most prevalent in cannabis.
• So if you have a hemp gummy or a hemp drink with a cannabinoid in it, that is not FDA approved.
• When you extract the cannabinoids and put them into a product, it becomes the weight of the product and
• >> So there are currently two or three FDA-approved cannabinoid-based drugs.

Bills: HB1974, HB1853, HB1973, HB1574, HB2619, HB1966, HB1643, HB1671, HB2558, HB1854, HB2173, HB1575, HB2229, HB1535, HB1978, HB2508, HB1549, HB2187, HB1550, HB1977, HB2314, HB1871, HB2319, HB1591, HB1858, HB1898, HB2372, HB1765, HB2012, HB1706, HB1962, HB1963, HB1975, HB2009, HB2083, HB2224, HB1877, HB1959, HB1626, HB1665, HB2488, HB2456, HB2548, HB2207, HB1832, HB2079, HB1985, HB1618, HB2486, HB2242, HB2045, HB1703, HB2236, HB2480, HB1976, HB2287, HB2288, HB1777, HB276, HB1660, HB1676, HB1605, HB1751, HB1967, HB2383, HB2340, HB1946, HB2268, HB1950, HB2156, HB2118, HB1859, HB1863, HB1996, HB2114, HB2423, HB2429, HB2475, HB2534, HB2545, HB1813, HB1941, HB2474, HB2583, HB1576, HB1886, HB1939, HB2540, HB2590, HB2000, HB2163, HB2386, HB1691, HB1680, HB2516, HB1993, HB2442, HB1510, HB1958, HB1692

Keywords: HB1974, hearing loss, audiology, audiologist, hearing screening, hearing aids, cochlear implants, tele-audiology, communication access, assistive technology, speech-language pathology, deafness, hard of hearing, public health, kupuna, keiki, dementia, cognitive decline, fall prevention, State Health Planning and Development Agency

Transcript Highlights:

• And we disallow artificially derived cannabinoids from coming into the adult use side, which are allowed
• <01:25:47.200> uh disallow artificially derived uh disallow artificially derived uh cannabinoids
• um from coming into the cannabinoids um from coming into the adult<01:25:50.120> use<01:25:50.280
• Many times patients or adult use customers may be interested in products that have higher cannabinoids
• are more prevalent in hemp. cannabinoids other than THC, so CBD, cannabinoids other than THC, so CBD

Keywords: 1187, senate, all

Transcript Highlights:

• Synthetic cannabinoids killed Floridians every year and between 2020 excuse me 2022 2020 3 we saw a 50%
• increase in the number of deaths due to synthetic cannabinoids.
• We agree with removing synthetic cannabinoids from like Delta 8 from the market and we support common-sense

Keywords: 999, senate, all

Transcript Highlights:

• We're talking about 0.5 milligrams of all other cannabinoids per serving.
• The burden of ease would be to limit some of these fees, allow functional cannabinoids to be used more
• One is the limits on non-intoxicating cannabinoids. CBD is one of those cannabinoids.
• Limiting the non-intoxicating cannabinoids to 25, which was now raised to 100 in HF 1615, I'm grateful
• And that's a simple fix if you just add the word intoxicating cannabinoids should be locked up because

Keywords: 1187, senate, all

Transcript Highlights:

• than they are with the impact of marijuana and similar products like hemp with intoxicants and cannabinoids
• than they are with the impact of marijuana and similar products like hemp with intoxicants and cannabinoids
• than they are with the impact of marijuana and similar products like hemp with intoxicants and cannabinoids

Keywords: March 14, 2026 - Regular Session Part 2, 976, house, all

Transcript Highlights:

• There are a few other cleanup provisions in there related to adjustments to the amount. of cannabinoid
• I also own a cannabinoid emulsion company and sit on the board of the Hemp Beverage Alliance, the leading
• The first issue is the limits on non-intoxicating cannabinoids, which everyone has talked about already

Bills: HF1545, HF2426, HF1615, HF2403

Keywords: medical cannabis, cultivation, cannabinoid products, plant canopy, Minnesota statutes, cannabis, hemp, lower-potency, edibles, regulations, licensing, local control, consumer safety, age restrictions, commerce policy, financial institutions, insurance regulation, limited long-term care insurance, Medicare supplement, health insurance

Transcript Highlights:

• There are a few other cleanup provisions in there related to adjustments to the amount of cannabinoid
• c> I<00:08:25.680> also<00:08:25.919> own<00:08:26.000> a I also own a cannabinoid
• :54.080> on<00:18:54.240> non- The first issue is the limits on non-intoxicating cannabinoids

Keywords: 1183, house

Transcript Highlights:

• HB 1246 will set up a uniform regulatory system to assure that all intoxicating cannabinoids will be
• Thank you so much for allowing the community to participate. cannabinoids hp1 1246 will set up a cannabinoids
• <00:46:26.040> also intoxicating cannabinoids also intoxicating cannabinoids also Laboratory
• Another point I'd like to make is actually our biggest concern right now are the hemp cannabinoids that
• are right now disguised, or sorry, the high-intoxicating THC that are now disguised as hemp cannabinoid

Keywords: 910, house, all

Summary: The House Committees on Judiciary and Hawaiian Affairs and Agriculture and Food Systems heard testimony and began decision-making on HB 1246, which would establish the Hawaii Cannabis and Hemp Office within DCCA to regulate cannabis. Chair Tarnas described the bill as divisive and noted the hearing had received 95 testimonies in support, 135 in opposition, and 11 comments. Members were told the office would be administratively attached to DCCA, and the department emphasized it would not direct day-to-day operations. DCCA also raised concerns about banking access due to federal law, while the Department of Agriculture supported a one-plant, one-agency approach and noted its current authority over cannabis plant importation and movement. Several agencies and advocates supported the bill with cautions or requested amendments. The Department of Health said it appreciated the bill’s public health protections but remained concerned about increased adult-use access, youth mental health, pregnancy-related risks, and effects on developing brains; it requested a 12-month delayed effective date. The Attorney General’s office said legalization should include safeguards, recommended a longer implementation timeline and seed funding, and flagged issues in the bill involving impaired driving, open-container language, and penalties for under-21 possession. The Office of the Public Defender supported the bill but objected to new driving and possession offenses, saying existing law already covers impaired driving. Doctors for Drug Policy Reform supported the measure, citing regulation of intoxicating cannabinoids, testing, childproof packaging, and public education as public-health benefits. Opponents focused on youth access, public safety, and the bill’s broader social effects. The Honolulu Police Department opposed the bill over access and diversion concerns, and the City and County of Honolulu Prosecutor strongly opposed legalization, citing higher-potency cannabis, youth harms, psychiatric risks, and increased poison-center calls. The Hawaiʻi Substance Abuse Coalition argued legalization should wait until prevention programs are in place and funded first, while the Hawaiʻi Family Forum and Hawaiian Republican Women also opposed the measure, citing concerns about youth exposure, added bureaucracy, and taxpayer costs. The Tax Foundation of Hawaiʻi questioned the purpose of the proposed cannabis taxes, asking why cannabis should be taxed heavily if legalization is intended. The hearing continued with additional testimony after a brief audio issue for one testifier.

Transcript Highlights:

• session when we did this bill reflects individuals in the state of Florida who have died due to cannabinoids
• and synthetic cannabinoids.
• There are deaths also of individuals who have cannabinoids in their system, but that's not the cause

Summary: The Committee on Agriculture heard a presentation from Florida FFA state officers Gabby Howell and Macy Jordan, who described FFA and agricultural education as a three-part model of classroom instruction, supervised agricultural experience, and leadership development. They highlighted FFA membership growth, Florida’s more than 60,000 members, industry certifications, and state funding that allows all agriculture education students to participate at no cost. Members praised the students and the organization’s role in developing future agricultural leaders. The committee then took up SB 438, which would regulate hemp and hemp extract products, including THC-infused beverages, by adding testing, labeling, retail location, age, and event restrictions, along with penalties and $2 million for testing equipment. Senator Burton said the bill is intended to address public safety, prevent products with illegal THC levels from reaching consumers, and respond to the governor’s prior veto concerns, especially store location and regulation. An amendment clarifying final batch testing was adopted without objection. Testimony was mixed. Supporters, including beverage distributors, law enforcement, and some hemp beverage businesses, backed regulation and said the bill would improve safety and clarity, though some asked for changes to avoid treating specialty beverage retailers like liquor stores. Opponents and some hemp industry representatives argued the bill was too restrictive, would hurt small businesses, and could push products into the black market; they also objected to THC limits, event restrictions, and the proposed regulatory structure. After debate, the committee voted 6-0 to report CS for SB 438 favorably.

Transcript Highlights:

• alternative nicotine products, and alternative nicotine products, and alternative nicotine products, and psychoactive
• cannabonoids to provide for psychoactive cannabonoids to provide for psychoactive cannabonoids to provide

Bills: SJR 39, SJR 68, SCR 29, SCR 42, SB 30, SB 33, SB 37, SB 217, SB 240, SB 331, SB 393, SB 505, SB 530, SB 546, SB 552, SB 584, SB 586, SB 618, SB 619, SB 636, SB 732, SB 769, SB 801, SB 825, SB 826, SB 844, SB 847, SB 870, SB 884, SB 957, SB 1065, SB 1150, SB 1184, SB 1257, SB 1261, SB 1262, SB 1299, SB 1314, SB 1325, SB 1398, SB 1413, SB 1455, SB 1539, SB 1577, SB 1583, SB 1596, SB 1620, SB 1624, SB 1642, SB 1643, SB 1667, SB 1717, SB 1727, SB 1760, SB 1789, SB 1791, SB 1804, SB 1868, SB 1870, SB 1883, SB 1901, SB 1923, SB 1924, SB 1927, SB 1951, SB 1960, SB 1962, SB 1963, SB 2010, SB 2018, SB 2023, SB 2024, SB 2037, SB 2051, SB 2052, SB 2056, SB 2066, SB 2073, SB 2127, SB 2129, SB 2161, SB 2183, SB 2185, SB 2207, SB 2252, SB 2323, SB 2332, SB 2368, SB 2405, SB 2439, SB 2626, SB 2717, SB 2743, SB 2774, SB 2949, SB 1, SJR 36, SJR 50, SJR 63, SJR 68, SCR 12, SCR 39, SCR 38, SCR 37, SCR 42, SCR 29, SB 2023, SB 62, SB 666, SB 847, SB 284, SB 854, SB 1073, SB 810, SB 1539, SB 1505, SB 583, SB 957, SB 1502, SB 507, SB 1026, SB 1349, SB 1433, SB 1434, SB 264, SB 1364, SB 1376, SB 1585, SB 1772, SB 2016, SB 1163, SB 619, SB 1122, SB 1877, SB 732, SB 731, SB 397, SB 508, SB 1436, SB 287, SB 2143, SB 261, SB 1247, SB 1882, SB 618, SB 393, SB 2243, SB 1919, SB 1791, SB 651, SB 826, SB 1079, SB 1243, SB 1504, SB 1851, SB 1879, SB 2237, SB 1257, SB 2034, SB 1522, SB 1151, SB 596, SB 1191, SB 226, SB 570, SB 870, SB 991, SB 60, SB 1401, SB 1728, SB 586, SB 529, SB 217, SB 209, SB 1923, SB 1839, SB 387, SB 1874, SB 1872, SB 1873, SB 1921, SB 1883, SB 1620, SB 1838, SB 2024, SB 2429, SB 1999, SB 511, SB 2309, SB 2166, SB 510, SB 1860, SB 1314, SB 1398, SB 855, SB 2037, SB 1759, SB 1924, SB 1818, SB 1762, SB 1968, SB 1977, SB 2077, SB 2321, SB 1662, SB 1663, SB 2124, SB 2204, SB 1855, SB 863, SB 2252, SB 2253, SB 825, SB 1184, SB 2018, SB 2206, SB 1901, SB 2368, SB 1963, SB 1960, SB 1643, SB 1625, SB 1299, SB 841, SB 668, SB 584, SB 231, SB 1085, SB 2431, SB 2231, SB 1490, SB 530, SB 1261, SB 2180, SB 1804, SB 1937, SB 1936, SB 2569, SB 1372, SB 1868, SB 2314, SB 769, SB 1409, SB 434, SB 1214, SB 1951, SB 2183, SB 2046, SB 1667, SB 1870, SB 1727, SB 2405, SB 2127, SB 1975, SB 1760, SB 1734, SB 1335, SB 2066, SB 2129, SB 2246, SB 2439, SB 1624, SB 1244, SB 1468, SB 2717, SB 1612, SB 1262, SB 604, SB 2395, SB 2185, SB 1832, SB 1745, SB 1746, SB 2207, SB 1784, SB 1524, SB 528, SB 437, SB 269, SB 1137, SB 968, SB 636, SB 747, SB 1325, SB 1789, SB 1455, SB 2056, SB 1940, SB 2052, SB 2010, SB 1579, SB 2068, SB 3034, SB 844, SB 1920, SB 1558, SB 1236, SB 1044, SB 884, SB 463, SB 331, SB 227, SB 240, SB 517, SB 1200, SB 1410, SB 1626, SB 1845, SB 1863, SB 2216, SB 2681, SB 1717, SB 2053, SB 546, SB 2141, SB 2949, SB 2323, SB 2200, SB 2332, SB 2199, SB 1642, SB 1150, SB 1757, SB 2050, SB 1138, SB 2051, SB 2626, SB 2458, SB 1864, SB 2201, SB 1862, SB 1583, SB 1055, SB 2660, SB 1898, SB 2662, SB 2161, SB 2964, SB 2881, SB 1065, SB 801, SB 2743, SB 2533, SB 1413, SB 2073, SB 3014, SB 3013, SB 2774, SB 2702, SB 2629, SB 2443, SB 2349, SB 2167, SB 2145, SB 2121, SB 758, SB 648, SB 647, SB 512, SB 438, SB 1721, SB 2268, SB 1495, SB 2705, SB 2366, SB 1422, SB 1369, SB 1013, SB 682, SB 2692, SB 2570, SB 2797, SB 2111, SB 1896, SB 1164, SB 1020, SB 663, SB 2371, SB 1152, SB 2196, SB 2383, SB 2581, SB 2798, SB 330, SB 646, SB 843, SB 1998, SB 1418, SB 2788, SB 1169, SB 2873, SB 1754, SB 1534, SB 1718, SB 2779, SB 2004, SB 1143, SB 1756, SB 912, SB 2119, SB 2032, SB 527, SB 1580, SB 1952, SB 2601, HJR 4, SJR 85, SJR 84, SCR 4, SCR 18, SCR 43, SCR 46, SB 2322, SB 2448, SB 1777, SB 1283, SB 407, SB 2392, SB 2076, SB 2786, SB 3031, SB 2877, SB 2876, SB 2284, SB 2225, SB 1540, SB 2920, SB 2929, SB 1395, SB 1972, SB 2540, SB 1183, SB 2742, SB 2595, SB 2217, SB 2117, SB 715, SB 2330, SB 1964, SB 1383, SB 500, SB 1640, SB 39, SB 2001, SB 2080, SB 2722, SB 506, SB 2514, SB 2623, SB 2658, SB 1574, SB 2900, SB 23, SB 2753, SB 2398, SB 401, SB 1241, SB 2927, SB 2173, SB 2538, SB 898, SB 467, SB 1449, SB 2529, SB 1531, SB 2846, SB 2476, SB 2031, SB 986, SB 1181, SB 2075, SB 2154, SB 2864, SB 2, SB 260, SJR 68, SB 217, SB 331, SB 530, SB 546, SB 586, SB 1150, SB 1184, SB 1261, SB 1398, SB 1620, SB 1923, SB 1951, SB 1960, SB 2051, SB 2129, SB 2183, SB 2185, SB 2252, SB 2368, SB 2405, SB 2949, SB 825, SB 1870, SB 2010, SR 434, SB 3048, SB 3049, SB 3050, SB 3051, SB 3052, SB 3053, SB 3055, SB 3048, SB 3049, SB 3050, SB 3051, SB 3052, SB 3053, SB 3055

Keywords: constitutional amendment, veto override, legislature power, governor, Texas Constitution, impeachment, public officers, removal from office, disqualification, El Paso, Boot Capital, cultural heritage, economic development, Western footwear, gender identity, biological sex, women's rights, immutability, policy, higher education

Transcript Highlights:

• bringing on some new technologies and drugs that will help us with the new and emerging synthetic cannabinoids
• And drugs that will help us with the new and emerging synthetic cannabinoids and being able to better

Summary: The committee met with representatives from the Arkansas State Crime Lab for what members said was likely the first appearance by the lab before this committee. Lab officials gave an overview of the new crime lab facility now under construction, saying it is on schedule, under budget, and expected to be completed by the end of July next year, with phased move-in beginning around August 1. They explained that the current building is over 40 years old and overcrowded, with caseloads having doubled over the past 20 years, and said the new facility will improve workflow, add morgue capacity, and allow new technologies and equipment to be brought online. Members asked about staffing and recruitment, and the lab said recent pay changes and legislative support have made Arkansas more competitive for forensic specialists and medical examiners. Officials said vacancies have been reduced, a new deputy chief medical examiner has been hired, two more medical examiners are starting in August, and a new fellowship program has already attracted applicants. They also said the lab is prepared for the staffing needs of the new facility and that training periods remain long for many analyst positions. The discussion also covered rapid DNA, CODIS, sexual assault kit processing, genetic genealogy, and overdose-related data sharing. The lab said rapid DNA is in final testing with pilot agencies in Faulkner and Saline counties and could go live by the end of July, which would make Arkansas among the first states to do so. Officials described CODIS as a key investigative tool, said DNA profiles are entered automatically when they qualify, and reported that the sexual assault kit backlog has been cleared with the lab now maintaining a 60-day turnaround. They also confirmed Arkansas uses a kit-tracking system, works with private labs such as Othram and Bode for genetic genealogy, and is developing an overdose dashboard to share toxicology and overdose data with public health and law enforcement partners. Members praised the lab’s progress and the committee adjourned after announcing an August site visit to Lake Conway and the dam project.

Bills: HR1037, HR1043, SB1491, SB1451, SB1286, SB1581, SB1521, SB201, SB1290, SB169, SB1377, SB1991, SB1346, SB1509, SB1928, SB2028, SB2071, SB2110, SB2117, SB2127, SB2134, SB722, SB3

Keywords: National Poetry Month, poetry, education, cultural celebration, arts and humanities, child abuse, prevention, community support, family safety, child welfare, presidential electors, vacancies, oath of office, political party, elections, voter registration, election integrity, Secretary of State, cancellation of registration, gender neutrality

Transcript Highlights:

• SB 3 by Perry relating to the regulation of consumable hemp products and the hemp-derived cannabinoids
• Of consumable hemp products and the hemp-derived cannabinoids contained in those products requiring a
• number SB. by Perry relating to the regulation of consumable hemp products and the hemp-derived cannabinoids
• It is important to note that hemp is defined as a cannabinoid plant with a percentage of Delta-9 THC.
• Finally, it will clarify that the milligram cap is specific to Delta-9 THC. and not all cannabinoids

Bills: SB31, SB33, SB20, SB217, SB264, SB269, SB650, SB681, SB528, SB502, SB740, SB916, SB995, SB10, SB2581, SB2570, SB3031, SB24, SB379, SB1171, SB1121, SB1120, SB1061, SB1036, SB1019, SB890, SB11, SB868, SB1188, SB1254, SB2778, SB2543, SB2443, SB1333, SB1259, SB1401, SB1404, SB2139, SB2165, SB2237, SB2268, SB1202, SB1198, SB1212, SB1451, SB1470, SB1498, SB965, SB1547, SB1667, SB1818, SB1902, SB2129, SB2078, SB2069, SB1737, SB1589, SB1318, SB387, SB1150, SB1574, SB2127, SB3034, SB860, SB1278, SCR5, SCR32, SB4, SB23, SB1762, SB34, SB60, SB706, SB1814, SB1220, SB523, SB565, SB1253, SB840, SB764, SB2383, SB2155, SB1535, SB1423, SB1566, SB1804, SB1728, SB1816, SB1952, SB75, SB2068, SB1455, SB213, SB627, SB2037, SB670, SB896, SB917, SB1184, SB971, SB1255, SB1261, SB1283, SB991, SB1733, SB21, SB231, SB739, SB1252, SB1371, SB646, SB3, SCR27, SB552, SB1405, SB1948, SB243, SJR1, SB31, SB33, SB20, SB217, SB264, SB269, SB650, SB681, SB528, SB502, SB740, SB916, SB995, SB10, SB2581, SB2570, SB3031, SB24, SB379, SB1171, SB1121, SB1120, SB1061, SB1036, SB1019, SB890, SB11, SB868, SB1188, SB1254, SB2778, SB2543, SB2443, SB1333, SB1259, SB1401, SB1404, SB2139, SB2165, SB2237, SB2268, SB1202, SB1198, SB1212, SB1451, SB1470, SB1498, SB965, SB1547, SB1667, SB1818, SB1902, SB2129, SB2078, SB2069, SB1737, SB1589, SB1318, SB387, SB1150, SB1574, SB2127, SB3034, SB860, SB1278, SCR5, SCR32, SB546, SB647, SB648, SB1493, SB1709, SB2001, HB5669, HB3115, HB5655, HB5675, HB5689, HB5690, HB5653, HB3228, HB2802, HB45, HB1318, HB5560, HB2894, HB4344, HB2775, HB33, HB 12, HB148

Keywords: SB 31, Life of the Mother Act, Texas abortion law, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, spontaneous abortion, miscarriage, unborn child, abortion exception, abortion ban, physician liability, health care liability claim, aiding and abetting, Texas Medical Board, State Bar of Texas, continuing medical education

Transcript Highlights:

• is in section two of the bill, already prohibits the use of synthetic and artificially derived cannabinoids
• <00:30:42.320> in<00:30:42.519> manufactured<00:30:43.080> hemp cannabinoids in
• manufactured hemp cannabinoids in manufactured hemp products<00:30:44.279> however<00:30:44.480
• But the bill does not include or cover the terms that are used, cannabinoids, masking today on a lot
• Carla Lua continued: The bill does not include or cover the terms that are used, cannabinoids masking

Keywords: 910, house, all

Summary: The committee first heard House Bill 302, which would repeal the requirement that a provider-patient relationship for medical cannabis certification be established in person first. The Department of Health said it supported the House Draft 2 version as a way to expand patient access, and several testifiers from the medical cannabis community and dispensary industry supported the bill, especially for patients on outer islands or those unable to travel. One witness asked that earlier language removed in committee be restored to further improve access. Representative Shimizu asked whether follow-up in-person visits would still occur, and DOH responded that this varies by provider, with some continuing in-person care and others moving to telehealth for chronic conditions. The committee then took up House Bill 712, relating to the federal 340B drug pricing program and contract pharmacies. The Office of Consumer Protection and the Attorney General’s office both said they supported the bill’s purpose but wanted it clarified and possibly moved into a standalone chapter rather than chapter 481B. Supporters, including Hawaii Pacific Health and the Queen’s Health Systems, said the bill is needed to protect safety-net funding and access to discounted drugs, citing large financial benefits from 340B and losses caused by manufacturer restrictions on contract pharmacies. PhRMA opposed the bill, arguing the issue is not access to discounts but accountability and transparency in how contract pharmacies distribute benefits, and said it was willing to discuss amendments. Members asked follow-up questions about whether there was data showing misuse; PhRMA said it did not have numbers, while hospital witnesses said the program is federally audited and used appropriately in Hawaii. Finally, the committee heard House Bill 1482, HD1, which would tighten hemp and controlled-substance definitions to exclude Schedule I cannabinoids from manufactured hemp products and clarify the treatment of artificially derived cannabis. The Department of Health supported the measure, saying it adds clarity to existing prohibitions. Kūre Hawaii and other supporters said it would close loopholes involving Delta-8 and similar products. An individual testifier urged stronger language to also cover compounds such as HHC, THCA, THCP, and THCO. In response to questions about enforcement against mislabeled hemp products, DOH explained that THC percentages are relative to product weight, that some products can remain under the hemp threshold while still containing significant THC, and that hemp flower is already prohibited from direct retail sale, though enforcement can be complicated and involves both administrative and criminal authorities.

Transcript Highlights:

• epidemic of K2, Compounding this threat of physical violence is this epidemic of K2, a synthetic cannabinoid
• It would rightly classify synthetic cannabinoids like K2 as a controlled substance, giving law enforcement
• House Bill 2702 appropriately recognizes the dangers posed by synthetic cannabinoids such as K2, which

Keywords: 995, all

Summary: The committee heard testimony on a wide range of public safety bills, with strong support from law enforcement, advocates, and other stakeholders. Several measures focused on police and correctional officer wellness and protections, including bills on critical incident leave and post-incident support for officers, a bill to improve POST Commission representation, and a bill to protect correctional officers from assaults and exposure to synthetic drugs like K2. Witnesses described traumatic incidents, rising assaults in prisons, staffing shortages, and the need for confidentiality in peer-support debriefings. Committee members asked questions about assault classifications, K2 smuggling, tablet-related contraband, and whether counseling records would remain confidential. No votes were taken during the hearing. A major portion of the hearing was devoted to canine-related bills. Testimony supported creating a fund for retired police dogs and expanding emergency care training for working dogs injured in the line of duty. Speakers described police dogs as partners who locate suspects, missing persons, drugs, and weapons, and said retirement and medical costs are currently borne by handlers or nonprofits. The committee also heard testimony in favor of a purple alert system for missing people with intellectual and developmental disabilities, with advocates citing wandering risks, drowning dangers, and data from other states showing faster recovery times. The committee also heard testimony on a bill to expand the definition of sexual assault by an officer to cover situations beyond formal custody, including investigations and other encounters where police have coercive power. Advocates for sex workers and anti-trafficking organizations said the change would close a loophole, protect vulnerable people, and address documented abuses. In addition, testimony was taken on a bill to protect Massachusetts residents from federal surveillance through fusion centers, with critics calling for stronger oversight of BRIC and related databases. Representative Jeff Turco also testified on bills to change POST Commission membership, arguing for more law enforcement representation.